(a) [(1)] The commission shall place a substance in Schedule V upon finding that:

(1) [(a)] the substance has low potential for abuse relative to the controlled substances included in Schedule IV;

(2) [(b)] the substance has currently accepted medical use in treatment in the United States; and

(3) [(c)] abuse of the substance may lead to limited physical dependence or psychological dependence relative to the substances included in Schedule IV.

(b) [(2)] The commission may place a substance in Schedule V without being required to make the findings required by subsection (a) [(1)] of this section if the substance is controlled under Schedule V of the federal Controlled Substances Act by a federal agency as the result of an international treaty, convention, or protocol.